Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor Board.
Green MF, Watson CH, Tait S, He J, Pavlick DC, Frampton G, Riedel J, Plichta JK, Armstrong AJ, Previs RA, Kauff N, Strickler JH, Datto MB, Berchuck A, Menendez CS. Green MF, et al. Among authors: strickler jh. Oncologist. 2023 Jan 18;28(1):33-39. doi: 10.1093/oncolo/oyac164. Oncologist. 2023. PMID: 35962742 Free PMC article.
Development of a Novel c-MET-Based CTC Detection Platform.
Zhang T, Boominathan R, Foulk B, Rao C, Kemeny G, Strickler JH, Abbruzzese JL, Harrison MR, Hsu DS, Healy P, Li J, Pi C, Prendergast KM, Hobbs C, Gemberling S, George DJ, Hurwitz HI, Connelly M, Garcia-Blanco MA, Armstrong AJ. Zhang T, et al. Among authors: strickler jh. Mol Cancer Res. 2016 Jun;14(6):539-47. doi: 10.1158/1541-7786.MCR-16-0011. Epub 2016 Mar 7. Mol Cancer Res. 2016. PMID: 26951228
Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers.
Watson CH, Broadwater G, Wong J, Spinosa D, de Oca MKM, Datto M, Green M, Hubbard C, McKinney M, McCall SJ, Havrilesky LJ, Strickler JH, Berchuck A, Strickland KC, Previs RA. Watson CH, et al. Among authors: strickler jh. Target Oncol. 2021 Jan;16(1):109-118. doi: 10.1007/s11523-020-00785-z. Epub 2021 Jan 5. Target Oncol. 2021. PMID: 33400095
Implementation of a Molecular Tumor Registry to Support the Adoption of Precision Oncology Within an Academic Medical Center: The Duke University Experience.
Green MF, Bell JL, Hubbard CB, McCall SJ, McKinney MS, Riedel JE, Menendez CS, Abbruzzese JL, Strickler JH, Datto MB. Green MF, et al. Among authors: strickler jh. JCO Precis Oncol. 2021 Sep 16;5:PO.21.00030. doi: 10.1200/PO.21.00030. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34568718 Free PMC article.
Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas.
Caughey BA, Umemoto K, Green MF, Ikeda M, Lowe ME, Ueno M, Niedzwiecki D, Taniguchi H, Walden DJ, Komatsu Y, D'Anna R, Esaki T, Denda T, Datto MB, Bando H, Bekaii-Saab T, Yoshino T, Strickler JH, Nakamura Y. Caughey BA, et al. Among authors: strickler jh. J Gastrointest Oncol. 2023 Oct 31;14(5):2083-2096. doi: 10.21037/jgo-23-114. Epub 2023 Sep 19. J Gastrointest Oncol. 2023. PMID: 37969845 Free PMC article.
128 results